Global Fetal Bovine Serum market will reach 1590 million US$ by the end of 2025
Published Date: 2018/12/27
Fetal bovine serum is the remained blood fraction after the natural coagulation of blood, which is obtained by centrifugation to remove any remaining red blood cells.
The raw material of fetal bovine serum is fetal bovine blood. The FBS suppliers make contract with beef processer or agent and gather fetal bovine blood at certain time. The production of FBS is quite seasonal because the raw material source can only be acquired twice a year. The primary factor and main market-driver is the beef processing industry, since FBS is produced as a byproduct of this industry. Since 2014, the price of FBS has been raising quickly due to multiple factors, among which, the climate change and reduced cattle inventory might be the most important ones.
The primary application of FBS is to fortify cell culture media. It is the most common media supplement used for cell culture. Considering end use, the application of FBS can be classified as scientific research and industrial production. The development of biomedical and healthcare industry has been witnessed with rapid development for the past years. Consequently, though sera industry has experienced substantial changes for the past years, the demand of FBS has been creeping. We estimate that FBS would not be replaced by substitute in short time, but suppliers in emerging market are in taking an increasing share, like Lanzhou Minhai and Zhejiang Tianhang Biotechnology.
The global Fetal Bovine Serum market is valued at 890 million US$ in 2017 and will reach 1590 million US$ by the end of 2025, growing at a CAGR of 7.6% during 2018-2025.
Click to view the full report: https://www.qyresearch.com/index/detail/161728/global-fetal-bovine-serum-sales-market
Marketing: sales@qyresearchglobal.com
Media Contact: press@qyresearch.com
评论
发表评论